verapamil has been researched along with Peripheral Nerve Diseases in 5 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A patient with pre-existing peripheral neuropathy developed generalized fasciculations under verapamil which ceased after discontinuation of the drug." | 7.68 | Fasciculations due to verapamil in a patient with neuropathy. ( Hopf, HC; Röder, R; Thömke, F; Vogt, T, 1990) |
| "A patient with pre-existing peripheral neuropathy developed generalized fasciculations under verapamil which ceased after discontinuation of the drug." | 3.68 | Fasciculations due to verapamil in a patient with neuropathy. ( Hopf, HC; Röder, R; Thömke, F; Vogt, T, 1990) |
| "Paclitaxel neurotoxicity was exacerbated with concomitant P-gp inhibition by valspodar and verapamil, consistent with increased intracellular accumulation of paclitaxel." | 1.56 | P-Glycoprotein Inhibition Exacerbates Paclitaxel Neurotoxicity in Neurons and Patients With Cancer. ( Hammer, HS; Khalaf, S; Kroetz, DL; Mortensen, C; Nielsen, F; Poetz, O; Rodriguez-Antona, C; Stage, TB; Steffensen, V; Svenningsen, ÅF; Xiong, C, 2020) |
| "Verapamil was given im in doses of 7 mg/kg/day for 4 days beginning 24 hr before administration of PSP (2." | 1.28 | Effect of verapamil on organophosphorus-induced delayed neuropathy in hens. ( Ehrich, M; el-Fawal, HA; Jortner, BS, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stage, TB | 1 |
| Mortensen, C | 1 |
| Khalaf, S | 1 |
| Steffensen, V | 1 |
| Hammer, HS | 1 |
| Xiong, C | 1 |
| Nielsen, F | 1 |
| Poetz, O | 1 |
| Svenningsen, ÅF | 1 |
| Rodriguez-Antona, C | 1 |
| Kroetz, DL | 1 |
| Wu, YJ | 1 |
| Leng, XF | 1 |
| Mix, E | 1 |
| Correale, J | 1 |
| Olsson, T | 1 |
| Solders, G | 1 |
| Link, H | 1 |
| Thömke, F | 1 |
| Vogt, T | 1 |
| Röder, R | 1 |
| Hopf, HC | 1 |
| el-Fawal, HA | 1 |
| Jortner, BS | 1 |
| Ehrich, M | 1 |
5 other studies available for verapamil and Peripheral Nerve Diseases
| Article | Year |
|---|---|
P-Glycoprotein Inhibition Exacerbates Paclitaxel Neurotoxicity in Neurons and Patients With Cancer.
Topics: Antineoplastic Agents, Phytogenic; Atorvastatin; ATP Binding Cassette Transporter, Subfamily B, Memb | 2020 |
Comparison of effects of verapamil and quercetin on delayed polyneuropathy induced by Tri-o-cresyl phosphate in hens.
Topics: Animals; Calcium; Calcium Channel Blockers; Calcium-Transporting ATPases; Chickens; Enzyme Inhibitor | 1997 |
Calcium antagonists suppress experimental allergic neuritis (EAN).
Topics: Action Potentials; Animals; Dose-Response Relationship, Drug; Flunarizine; Lymphocyte Activation; Ne | 1992 |
Fasciculations due to verapamil in a patient with neuropathy.
Topics: Aged; Arrhythmias, Cardiac; Fasciculation; Humans; Male; Peripheral Nervous System Diseases; Verapam | 1990 |
Effect of verapamil on organophosphorus-induced delayed neuropathy in hens.
Topics: Acetylcholine; Animals; Calcium; Carboxylic Ester Hydrolases; Chickens; Denervation; Dose-Response R | 1989 |